Attorney General Ken Paxton Files Lawsuit Against Pfizer and Tris Pharma Over Medicaid Fraud and Distribution of Adulterated Drugs to Texas Children
In a bold move to address corporate malpractice in drug manufacturing, Texas Attorney General Ken Paxton has announced the filing of a lawsuit against pharmaceutical giants Pfizer, Inc., Tris Pharma, Inc., and Tris Pharma CEO Ketan Mehta.
The companies are accused of engaging in deceitful practices that resulted in defrauding the Texas Medicaid program by providing adulterated pharmaceutical drugs specifically designed for children.
The lawsuit, brought forth by the Attorney General’s Civil Medicaid Fraud Division, leverages the provisions of the Texas Health Care Program Fraud Prevention Act (THFPA).
Paxton’s office stated that Pfizer and Tris Pharma collaborated to produce and distribute Quillivant XR, a medication developed for pediatric attention-deficit/hyperactivity disorder (ADHD), despite recurring failure in quality control assessments.
